More than 3,000 women were tested pan-India between 2013 and 2017 for High Risk HPV infection by using the global standard method - Hybrid Capture II
Human papillomavirus testing using hybrid capture II
with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method.
A study from Allahabad, India, reported 27.4% HPV detection in OSF while it was detected in 31.53% cases of OSCC on brush biopsy specimen by Hybrid Capture II
(5) The Hybrid Capture II
(Qiagen) is a method widely used in many countries and is able to detect 18 HPV types.
Patients with atypical epithelial cells on cytological smear underwent parallel testing for high-risk HPV types with the Hybrid Capture II
Prevalence and typing of HPV DNA by hybrid capture II
in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests.
Participants were selected to undergo a primary HPV DNA test (hybrid capture II
) with cytology triage if the result was positive, or a conventional cytologic screening.
Only the Digene Hybrid Capture II
is approved by the US.
For high-risk HPV only the swabs were adequate using one of the laboratory tests (Digene Hybrid Capture II
), but both the tampon and swab were acceptable when a second test (Roche Reverse Line Blot Assay) was used.
trachomatis testing using Digene's Hybrid Capture II
CT-ID test (Digene Corp., Gaithersburg, Maryland, United States).
This study was undertaken to compare the diagnostic accuracy of HPV testing by hybrid capture II
(HC-II) with conventional cervical smear cytology for squamous intraepithelial lesions (SIL).
In a separate vote, ACIP also recommended vaccination for women with an equivocal or abnormal Pap test, those who have tested positive for HPV infection using the Hybrid Capture II
, and for those with genital warts.